Yokohama, Japan

Toyoaki Ishikura


Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Yokohama, JP (1990 - 2007)
  • Kanagawa-Ken, JP (2007)

Company Filing History:


Years Active: 1990-2007

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Toyoaki Ishikura: Innovator in Antiallergic Agents

Introduction

Toyoaki Ishikura is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. With a total of 5 patents to his name, Ishikura's work has had a considerable impact on medical science.

Latest Patents

Ishikura's latest patents include innovative compounds such as tricyclic triazolobenzazepine derivatives. These compounds are designed to serve as antiallergic agents and exhibit excellent bioavailability. One of his notable inventions is a process for producing these derivatives in the form of a prodrug. Additionally, he has developed an amorphous substance of tricyclic triazolobenzazepine derivative, which possesses improved absorption and dissolvability. This invention includes a pharmaceutical composition that enhances the effectiveness of the compound.

Career Highlights

Throughout his career, Ishikura has worked with prominent companies such as Meiji Seika Kaisha, Ltd. and Showa Denko Kabushiki Kaisha. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Ishikura has collaborated with esteemed colleagues, including Yasuo Ohtsuka and Toshio Nishizuka. These partnerships have fostered a collaborative environment that has led to innovative solutions in the field of pharmaceuticals.

Conclusion

Toyoaki Ishikura is a distinguished inventor whose work in antiallergic agents has made a significant impact on medical science. His innovative patents and collaborations highlight his dedication to advancing pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…